Veradigm (NASDAQ:MDRX) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX) in a research note issued to investors on Saturday morning. The brokerage issued a hold rating on the software maker’s stock.

Separately, TD Cowen dropped their price target on Veradigm from $26.00 to $15.00 and set a buy rating on the stock in a research note on Tuesday, May 28th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of Hold and a consensus price target of $12.00.

Veradigm Price Performance

Veradigm stock opened at $9.90 on Friday. The stock has a fifty day simple moving average of $9.66 and a two-hundred day simple moving average of $8.77. Veradigm has a 12 month low of $5.01 and a 12 month high of $14.09.

Hedge Funds Weigh In On Veradigm

A number of institutional investors and hedge funds have recently modified their holdings of MDRX. Truist Financial Corp lifted its position in Veradigm by 27.8% during the fourth quarter. Truist Financial Corp now owns 38,911 shares of the software maker’s stock valued at $408,000 after purchasing an additional 8,473 shares in the last quarter. Victory Capital Management Inc. lifted its position in Veradigm by 27.0% during the fourth quarter. Victory Capital Management Inc. now owns 40,947 shares of the software maker’s stock valued at $430,000 after purchasing an additional 8,710 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in Veradigm by 8.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,087,605 shares of the software maker’s stock valued at $21,899,000 after purchasing an additional 171,199 shares in the last quarter. Teacher Retirement System of Texas lifted its position in Veradigm by 1.8% during the fourth quarter. Teacher Retirement System of Texas now owns 74,821 shares of the software maker’s stock valued at $785,000 after purchasing an additional 1,331 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its position in Veradigm by 54.7% during the fourth quarter. BNP Paribas Financial Markets now owns 101,276 shares of the software maker’s stock valued at $1,062,000 after purchasing an additional 35,797 shares in the last quarter.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.